General practitioner's adherence to the COPD GOLD guidelines: baseline data of the Swiss COPD Cohort Study.
about
Appropriate use of inhaled corticosteroids in COPD: the candidates for safe withdrawalMissing potential opportunities to reduce repeat COPD exacerbations.Simulation curriculum can improve medical student assessment and management of acute coronary syndrome during a clinical practice exam.Risk of pneumonia in obstructive lung disease: A real-life study comparing extra-fine and fine-particle inhaled corticosteroids.Differences in classification of COPD patients into risk groups A-D: a cross-sectional study.Treatment evolution after COPD diagnosis in the UK primary care setting.Management of COPD in the UK primary-care setting: an analysis of real-life prescribing patterns.Implementing clinical guidelines for chronic obstructive pulmonary disease: barriers and solutions.LANTERN: a randomized study of QVA149 versus salmeterol/fluticasone combination in patients with COPD.The inevitable drift to triple therapy in COPD: an analysis of prescribing pathways in the UK.Characteristics, disease burden and costs of COPD patients in the two years following initiation of long-acting bronchodilators in UK primary care.Categorization of COPD patients in Turkey via GOLD 2013 strategy document: ALPHABET study.First maintenance therapy for COPD in the UK between 2009 and 2012: a retrospective database analysis.The improving care in chronic obstructive lung disease study: CAROL improving processes of care and quality of life of COPD patients in primary care: study protocol for a randomized controlled trialChanges in initial COPD treatment choice over time and factors influencing prescribing decisions in UK primary care: in UK primary care: a real-world, retrospective, observational.Efficacy of Indacaterol/Glycopyrronium in Patients with COPD Who Have Increased Dyspnea with Daily Activities.Characteristics of newly diagnosed COPD patients treated with triple inhaled therapy by general practitioners: a real world Italian study.Use of Exhaled Nitric Oxide as a Biomarker in Diagnosis and Management of Chronic Obstructive Pulmonary Disease.Adherence to Long-Acting Bronchodilators After Discharge for COPD: How Much of the Geographic Variation is Attributable to the Hospital of Discharge and How Much to the Primary Care Providers?Effects of GOLD-Adherent Prescribing on COPD Symptom Burden, Exacerbations, and Health Care Utilization in a Real-World Setting.Efficacy of indacaterol 75 μg versus fixed-dose combinations of formoterol-budesonide or salmeterol-fluticasone for COPD: a network meta-analysis.The Laboratory-Based Intermountain Validated Exacerbation (LIVE) Score Identifies Chronic Obstructive Pulmonary Disease Patients at High Mortality Risk.
P2860
Q28074169-F85ABA4B-92E7-460E-8189-FBBB7C9300AAQ30539033-0DB58BCA-97EF-4882-AFC3-4AF4CE553C02Q33650975-6AE3DCD9-87AD-4868-9E8F-C7E59301DCA5Q33803143-05585B8D-87BE-4964-A8D2-D0FA2A6DB23EQ34107700-FE862BCE-2C42-43C3-8461-05BD601BD043Q34121263-D4298F5A-3EE0-4B81-9EC9-698E762C6B20Q34134884-71BE678C-0E86-47A2-989F-5DEE2B208542Q34628637-F91A0B11-4467-4597-A5A6-DDF5FE9FB82AQ35703517-012B2EDD-335F-4EDD-A6A6-6A8184C40857Q36208427-386F6559-BFD6-4FBD-A446-082DC7CB3CCCQ36286968-4147B568-2DBC-4CC2-8C9D-A0F983F1CA36Q36303220-F99D0100-BD9E-4330-AFA1-A0DD7F43E722Q37390146-312BC7D5-71AE-4EF0-85E9-5BB8100F8EA9Q37703059-EDBA4F32-BE92-400C-A02C-C70A3D69798BQ37732345-45045AB6-7DE6-4815-B79B-5BE505F68060Q38604621-C710E56A-200A-4AB3-B7C3-042376DBC5BBQ40052187-BBF1F4FA-AB06-4DD5-B9BE-453F7741E084Q40156914-6A1399E4-5A10-4875-B212-9088B240C0DFQ40649862-F4FC0D55-E2E2-42BA-9D56-6E6080ECB405Q41400950-C852EF55-C4F2-4A53-8071-ADFE0ED9F9A8Q42044652-BBF44700-57F6-44F5-96CF-8535F45B7BA1Q55475810-4CE6A2F6-4B6E-46F1-B923-D6DDEB9BBA22
P2860
General practitioner's adherence to the COPD GOLD guidelines: baseline data of the Swiss COPD Cohort Study.
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
General practitioner's adheren ...... f the Swiss COPD Cohort Study.
@ast
General practitioner's adheren ...... f the Swiss COPD Cohort Study.
@en
General practitioner's adheren ...... f the Swiss COPD Cohort Study.
@nl
type
label
General practitioner's adheren ...... f the Swiss COPD Cohort Study.
@ast
General practitioner's adheren ...... f the Swiss COPD Cohort Study.
@en
General practitioner's adheren ...... f the Swiss COPD Cohort Study.
@nl
prefLabel
General practitioner's adheren ...... f the Swiss COPD Cohort Study.
@ast
General practitioner's adheren ...... f the Swiss COPD Cohort Study.
@en
General practitioner's adheren ...... f the Swiss COPD Cohort Study.
@nl
P2093
P356
P1433
P1476
General practitioner's adheren ...... f the Swiss COPD Cohort Study.
@en
P2093
P356
10.4414/SMW.2010.13053
P577
2010-04-21T00:00:00Z